<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000982.v1.p1" parentStudy="phs000982.v1.p1" createDate="2015-09-01" modDate="2015-09-01">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>James T. Elder</td><td>Department of Dermatology, University of Michigan, Ann Arbor, MI, USA</td></tr>
		<tr><td>Funding Source</td><td>R01AR042742</td><td>National Institute for Arthritis, Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Source</td><td>R01AR050511</td><td>National Institute for Arthritis, Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Source</td><td>R01AR054966</td><td>National Institute for Arthritis, Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Source</td><td>R01AR062382</td><td>National Institute for Arthritis, Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, MD, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Genetic Analysis of Psoriasis and Psoriatic Arthritis</StudyNameEntrez>
	<StudyNameReportPage>Genetic Analysis of Psoriasis and Psoriatic Arthritis: GWAS of Psoriatic Arthritis</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case-Control</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>This study is a genome-wide study of genetic associations with psoriatic arthritis (PsA), an inflammatory musculoskeletal condition that develops in up to 30% of people who have chronic psoriasis skin lesions. 1,526 cases affected with psoriatic arthritis and 1,508 unaffected controls were recruited and typed on the Illumina HumanOmni1-Quad BeadChip array. After application of quality control measures to both samples and SNPs, genotypes for 791,217 autosomal SNPs were available for 1,430 PsA cases and 1,417 controls. Imputation using phased haplotypes for the EUR subpopulation of release 3, phase 1 of the 1000 Genomes Project as a reference, resulted in genotypes for 11,532,644 SNPs and 918,976 indels passing our imputation quality threshold (Mach r<sup>2</sup> &#8805; 0.3) that were available for downstream analysis. Association at a genome-wide threshold of significance was found for five regions (near genes <i>TNIP1</i>, <i>IL12B</i>, <i>HLA-C</i>, <i>TRAF3IP2</i>, and <i>TYK2</i>).</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>Cases were all diagnosed by a rheumatologist as having psoriatic arthritis; most were evaluated using CASPAR criteria. Controls were at least 18 years of age and unaffected with either psoriasis or psoriatic arthritis. After genotyping on the Illumina array, we applied the usual quality controls measures to the samples. Samples were excluded if they represented a population outlier with substantial non-European admixture (determined with PCA), were duplicates or first or second degree relatives of other samples, had a genotype call rate &lt; 98%, had outlier values for inbreeding coefficient &#8805; 1.5 times the interquartile range beyond the lower or upper quartiles (F &lt; -0.0225 or F &gt; 0.0285), or were part of unresolvable sample swaps determined by X chromosome genotypes.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="25087609"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Arthritis, Psoriatic"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>James T. Elder</AttName>
			<Institution>Department of Dermatology, University of Michigan, Ann Arbor, MI, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>R01AR042742</AttName>
			<Institution>National Institute for Arthritis, Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>R01AR050511</AttName>
			<Institution>National Institute for Arthritis, Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>R01AR054966</AttName>
			<Institution>National Institute for Arthritis, Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>R01AR062382</AttName>
			<Institution>National Institute for Arthritis, Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>R01AR065187</AttName>
			<Institution>National Institute for Arthritis, Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyURLs>
		<Url name="Psoriasis Genetics Laboratory" url="http://www.psoriasis.umich.edu"/>
	</StudyURLs>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="GRU" longName="General Research Use"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NIAMS</DacName>
      <DacFullName>NIAMS</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000982.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000982.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000982.v1.p1" FileName=""/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use</ConsentName>
        <ConsentAbbrev>GRU</ConsentAbbrev>
        <UseLimitation>Use of the data is limited only by the terms of the model Data Use Certification.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>

<Analyses>
	<Analysis pha="3894" genomeBuild="38" snpBuild="146" analysisType="">
		<Description>This is a genome-wide study of genetic associations with psoriatic arthritis (PsA), an inflammatory musculoskeletal condition that develops in up to 30% of people who have chronic psoriasis skin lesions. 1,526 cases affected with psoriatic arthritis and 1,508 unaffected controls were recruited and typed on the Illumina HumanOmni1-Quad BeadChip array.</Description>
		<Method>categorical analysis</Method>
		<GtyPlatform probeNum="1041413" snpBatchId="1056553">
			<Vendor>Illumina</Vendor>
			<VendorURL>HumanOmni1-Quad_v1-0_H.csv</VendorURL>
			<Platform>HumanOmni1-Quad_v1-0</Platform>
		</GtyPlatform>
		<Comment></Comment>
	</Analysis>
</Analyses>

</Study>

</Studies>

</GaPExchange>
